[6] VALOPICITABINE (NM283), ALONE OR WITH PEG-INTERFERON, COMPARED TO PEG INTERFERON/RIBAVIRIN (PEGIFN/RBV) RETREATMENT IN PATIENTS WITH HCV-1 INFECTION AND PRIOR NON-RESPONSE TO PEGIFN/RBV: ONE-YEAR RESULTS

Autor:	E.J. Lawitz, Christopher B. O'Brien, Steven J. Knox, Nathaniel A. Brown, E. Godofsky, M.S. Sulkowski, G. Chao, Ira M. Jacobson, Maribel Rodriguez-Torres, Nezam H. Afdhal, Paul J. Pockros, K. Pietropaolo, Stephen C. Pappas
Rok vydání:	2007
Předmět:	medicine.medical_specialty Peg interferon chemistry.chemical_compound VALOPICITABINE Hepatology chemistry business.industry Internal medicine Ribavirin medicine In patient business Gastroenterology
Zdroj:	Journal of Hepatology. 46:S5
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(07)61604-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::18879db415b35e365681f5a74850b933 https://doi.org/10.1016/s0168-8278(07)61604-3 Zobrazit plný text záznamu Full Text from ScienceDirect